IL150842D0 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses - Google Patents

2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

Info

Publication number
IL150842D0
IL150842D0 IL15084201A IL15084201A IL150842D0 IL 150842 D0 IL150842 D0 IL 150842D0 IL 15084201 A IL15084201 A IL 15084201A IL 15084201 A IL15084201 A IL 15084201A IL 150842 D0 IL150842 D0 IL 150842D0
Authority
IL
Israel
Prior art keywords
oxo
preparing
processes
uses
pyrrolidine derivatives
Prior art date
Application number
IL15084201A
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to GBGB0004297.8A priority Critical patent/GB0004297D0/en
Application filed by Ucb Sa filed Critical Ucb Sa
Priority to PCT/EP2001/001992 priority patent/WO2001062726A2/en
Publication of IL150842D0 publication Critical patent/IL150842D0/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9886259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL150842(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
IL15084201A 2000-02-23 2001-02-21 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses IL150842D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0004297.8A GB0004297D0 (en) 2000-02-23 2000-02-23 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
PCT/EP2001/001992 WO2001062726A2 (en) 2000-02-23 2001-02-21 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

Publications (1)

Publication Number Publication Date
IL150842D0 true IL150842D0 (en) 2003-02-12

Family

ID=9886259

Family Applications (5)

Application Number Title Priority Date Filing Date
IL15084201A IL150842D0 (en) 2000-02-23 2001-02-21 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
IL15075701A IL150757D0 (en) 2000-02-23 2001-02-21 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
IL150842A IL150842A (en) 2000-02-23 2002-07-22 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
IL166768A IL166768A (en) 2000-02-23 2005-02-09 2-oxo-1-pyrrolidine derivatives and a process for their preparation
IL170181A IL170181A (en) 2000-02-23 2005-08-09 (4r) and (4s)-diastereoisomers of (2s)-2-[oxy-4-propylpyrrolidinyl]butanamide, pharmaceutical compositions comprising them and their use for preparing medicaments

Family Applications After (4)

Application Number Title Priority Date Filing Date
IL15075701A IL150757D0 (en) 2000-02-23 2001-02-21 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
IL150842A IL150842A (en) 2000-02-23 2002-07-22 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
IL166768A IL166768A (en) 2000-02-23 2005-02-09 2-oxo-1-pyrrolidine derivatives and a process for their preparation
IL170181A IL170181A (en) 2000-02-23 2005-08-09 (4r) and (4s)-diastereoisomers of (2s)-2-[oxy-4-propylpyrrolidinyl]butanamide, pharmaceutical compositions comprising them and their use for preparing medicaments

Country Status (41)

Country Link
US (12) US6713635B2 (en)
EP (8) EP1452524B1 (en)
JP (5) JP4081275B2 (en)
KR (2) KR100681580B1 (en)
CN (5) CN1740150A (en)
AT (5) AT325093T (en)
AU (5) AU778510B2 (en)
BG (4) BG65923B1 (en)
BR (2) BRPI0108664B1 (en)
CA (2) CA2401048C (en)
CO (2) CO5271667A1 (en)
CU (2) CU23201A3 (en)
CY (1) CY1109718T1 (en)
CZ (3) CZ304702B6 (en)
DE (5) DE60143493D1 (en)
DK (3) DK1452524T3 (en)
EG (1) EG24375A (en)
ES (5) ES2231501T3 (en)
GB (1) GB0004297D0 (en)
HK (2) HK1052695A1 (en)
HU (3) HU230270B1 (en)
IL (5) IL150842D0 (en)
IS (8) IS2119B (en)
LT (1) LTC1265862I2 (en)
LU (1) LU92993I2 (en)
ME (1) ME00595B (en)
MX (2) MXPA02008206A (en)
MY (3) MY140593A (en)
NL (1) NL300815I2 (en)
NO (5) NO324051B1 (en)
NZ (1) NZ520448A (en)
PL (3) PL213669B1 (en)
PT (2) PT1452524E (en)
RO (2) RO121559B1 (en)
RS (2) RS50455B (en)
RU (5) RU2355680C2 (en)
SA (2) SA1275B1 (en)
SI (1) SI1265862T1 (en)
TW (2) TW200626544A (en)
WO (2) WO2001062726A2 (en)
ZA (2) ZA200205671B (en)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7365093B2 (en) * 1994-08-19 2008-04-29 Abbott Laboratories Endothelin antagonists
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6686477B2 (en) 2000-09-29 2004-02-03 Eastman Chemical Company Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
CA2455155C (en) 2001-08-10 2012-04-10 Ucb, S.A. Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
EP1435943B1 (en) * 2001-10-08 2007-02-14 Ucb, S.A. Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug for treating dyskinesia
DE60233884D1 (en) 2001-10-16 2009-11-12 Memory Pharmaceutical Corp 4 (4-alkoxy-3-hydroxyphenyl) -2-pyrrolidone derivatives as PDE4 inhibitor for the treatment of neurological syndromes
WO2003094913A1 (en) * 2002-05-14 2003-11-20 Ucb, S.A. Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug
AT442200T (en) * 2003-01-13 2009-09-15 Ucb Pharma Sa hydrogenation
CA2515090A1 (en) * 2003-02-03 2004-08-19 Teva Pharmaceutical Industries Ltd Process for producing levetiracetam
ES2214147B1 (en) 2003-02-28 2005-10-01 Farma-Lepori S.A. Method for obtaining an antiepileptic agent.
TR200503397T1 (en) * 2003-03-18 2007-03-21 Hetero Drugs Limited novel crystalline forms of levetiracetam.
RU2232578C1 (en) * 2003-04-10 2004-07-20 Ахапкина Валентина Ивановна Substance eliciting antidepressant activity
JP2006523710A (en) 2003-04-16 2006-10-19 エフ.ホフマン ラ−ロシュ インコーポレイティド Phosphodiesterase 4 inhibitor
US7034051B2 (en) * 2003-08-28 2006-04-25 Adolor Corporation Fused bicyclic carboxamide derivatives and methods of their use
EP1663968A1 (en) * 2003-09-05 2006-06-07 Ranbaxy Laboratories Limited Process for the preparation of pure levetiracetam
DK1667967T3 (en) 2003-09-24 2012-10-08 Ucb Pharma Sa A process for the preparation of 2-oxo-1-pyrrolidine derivatives
DE602004019814D1 (en) 2003-12-02 2009-04-16 Ucb Pharma Sa Imidazole derivatives, processes for their preparation and their applications
CN1964942A (en) * 2004-06-11 2007-05-16 Ucb股份有限公司 Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation
EA015418B1 (en) * 2004-06-21 2011-08-30 УОРНЕР-ЛАМБЕРТ КОМПАНИ ЭлЭлСи Preparation of pregabalin and related compounds
US7427601B2 (en) * 2004-06-24 2008-09-23 Schwarz Pharma Ag Method for treating tremor
CN101166737A (en) * 2004-10-20 2008-04-23 记忆药物公司 Phosphodiesterase 4 inhibitors
CA2488325C (en) * 2004-11-22 2010-08-24 Apotex Pharmachem Inc. Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
JP2008542322A (en) 2005-06-01 2008-11-27 ユセベ ファルマ ソシエテ アノニム 2-oxo-1-pyrrolidine derivatives
EP1731149A1 (en) * 2005-06-08 2006-12-13 Ucb S.A. Use of 2-oxo-1-pyrrolidone derivatives for the treatment of diseases characterized by progressive myoclonic epilepsy
AU2006291524B2 (en) * 2005-09-15 2012-01-12 Ucb Pharma S.A 4-substituted pyrrolidin-2-ones and their use
JP2007153755A (en) * 2005-12-01 2007-06-21 Gifu Univ Proline analog
EP1993998B1 (en) * 2005-12-07 2013-08-21 UCB Pharma, S.A. 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
US8338621B2 (en) 2005-12-21 2012-12-25 Ucb S.A. Process for the preparation of 2-oxo-1-pyrrolidine derivatives
LV13630B (en) * 2006-03-16 2007-12-20 Olainfarm As Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
BRPI0712325A2 (en) * 2006-06-08 2012-01-10 Ucb Pharma Sa Process for the preparation of pyrrolidinones co-crystals, co-crystal, pharmaceutical composition and use of a co-crystal
PT2462990E (en) * 2006-06-15 2014-04-02 Ucb Pharma Gmbh Pharmaceutical composition comprising lacosamide and levetiracetam with synergistic anticonvulsant effect
WO2008021666A2 (en) * 2006-08-18 2008-02-21 Morton Grove Pharmaceuticals, Inc. Stable liquid levetiracetam compositions and methods
CN101595102B (en) * 2006-10-18 2013-08-07 辉瑞产品公司 Biaryl ether urea compounds
WO2008103319A2 (en) 2007-02-16 2008-08-28 Ark Diagnostics, Inc. Compounds and methods for use in detecting gabapentin
WO2008132139A2 (en) * 2007-04-27 2008-11-06 Ucb Pharma S.A. New heterocyclic derivatives useful for the treatment of cns disorders
US20090082422A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched levetiracetam
CN101945647B (en) * 2008-03-03 2013-01-09 Ucb医药有限公司 Pharmaceutical solutions, process of preparation and therapeutic uses
US7741327B2 (en) 2008-04-16 2010-06-22 Hoffmann-La Roche Inc. Pyrrolidinone glucokinase activators
US20110212944A1 (en) * 2008-07-01 2011-09-01 Julie Liu 2-oxo-1-pyrrolidine derivatives
EP2147911A1 (en) 2008-07-24 2010-01-27 ZaCh System S.p.A. Process for the preparation of levetiracetam
JP4644881B2 (en) * 2008-09-19 2011-03-09 高砂香料工業株式会社 Method for producing a ruthenium complex
WO2010044878A1 (en) 2008-10-16 2010-04-22 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2349335B1 (en) 2008-10-24 2013-08-07 ARK Diagnostics, Inc. Levetiracetam immunoassays
EP2341777B1 (en) * 2008-11-07 2015-01-21 NovaBay Pharmaceuticals, Inc. Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
US10172805B2 (en) * 2008-11-18 2019-01-08 Ucb Biopharma Sprl Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivative
KR101788804B1 (en) * 2008-11-18 2017-10-20 유씨비 파마, 에스.에이. Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate
FR2939311A1 (en) * 2008-12-08 2010-06-11 Oreal Use of pyrrolidinone diester derivative in a composition comprising liquid fatty phase and lipophilic active agent in a medium, as solvent and/or as agent that improves the solubility of the active agent in the fatty phase
EP2393483B1 (en) 2009-02-09 2017-06-28 UCB Biopharma SPRL Pharmaceutical compositions comprising brivaracetam
US8846411B2 (en) * 2009-06-11 2014-09-30 Microgenics Corporation Derivatives, reagents, and immunoassay for detecting levetiracetam
WO2011015349A2 (en) 2009-08-07 2011-02-10 Ucb Pharma, S.A. Methods for enhancing the cognitive function
US7939676B2 (en) 2009-09-17 2011-05-10 Zach System S.P.A. Process for the preparation of levetiracetam
JP5808020B2 (en) 2009-10-23 2015-11-10 ユセベ ファルマ ソシエテ アノニム 2-oxo-1-pyrrolidinylmethyl imidazo thiadiazole derivatives
PL389364A1 (en) 2009-10-23 2011-04-26 Uniwersytet Jagielloński New applications of 2-pyrrolidone derivatives
US8487591B1 (en) 2009-12-31 2013-07-16 Cirrus Logic, Inc. Power control system with power drop out immunity and uncompromised startup time
AU2011215870B2 (en) 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
FR2961101B1 (en) 2010-06-09 2013-01-25 Oreal Composition comprising at least one 2-pyrrolidone functionalized with an ester or amide, and at least one pigment or a direct dye for dyeing keratin materials
FR2961098A1 (en) 2010-06-09 2011-12-16 Oreal Composition comprising at least one 2-pyrrolidone functionalized in position 4 by a carboxylic or amide acid, and at least one direct color or pigment for dying keratin fibers
FR2961099B1 (en) 2010-06-09 2012-06-15 Oreal Derivatives of 2-pyrrolidone functionalized with an ester group, acid or amide, the cosmetic composition comprising them and their use for conditioning keratinous substances
US8866452B1 (en) 2010-08-11 2014-10-21 Cirrus Logic, Inc. Variable minimum input voltage based switching in an electronic power control system
US9510401B1 (en) 2010-08-24 2016-11-29 Cirrus Logic, Inc. Reduced standby power in an electronic power control system
US8466297B2 (en) 2010-11-01 2013-06-18 Milan Soukup Manufacturing process for (S)-Pregabalin
CA2818025A1 (en) 2010-11-15 2012-05-24 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
CN103476255A (en) * 2011-02-09 2013-12-25 约翰斯霍普金斯大学 Methods and compositions for improving cognitive function
PT2699581E (en) 2011-04-18 2016-03-22 Ucb Biopharma Sprl 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
US9313840B2 (en) 2011-06-03 2016-04-12 Cirrus Logic, Inc. Control data determination from primary-side sensing of a secondary-side voltage in a switching power converter
CN107353316A (en) 2011-09-30 2017-11-17 塔夫斯大学 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
EP2797881B1 (en) * 2011-12-27 2018-11-14 Bio-Pharm Solutions Co., Ltd. Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
WO2014087367A2 (en) * 2012-12-09 2014-06-12 Mahesh Kandula Compositions and methods for the treatment of neurological diseases and its associated complications
TW201408294A (en) * 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa Use of (R)-phenylpiracetam for the treatment of Parkinson's disease
TW201408293A (en) * 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa Use of (R)-phenylpiracetam for the treatment of disease-associated fatigue
EP2900680A4 (en) 2012-09-28 2016-06-08 Univ Tufts Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
JP6440625B2 (en) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー The methods and compositions for treating schizophrenia
EP3406594A1 (en) 2012-12-07 2018-11-28 Merck Sharp & Dohme Corp. Biocatalytic transamination process
EP2945942B1 (en) 2013-01-18 2018-05-09 ARK Diagnostics, Inc. Voriconazole immunoassays
ES2674704T3 (en) 2013-02-13 2018-07-03 Ark Diagnostics, Inc. Immunoassays of posaconazole
US10138265B2 (en) 2013-03-13 2018-11-27 Tufts University Uridine nucleoside derivatives, compositions and methods of use
JP2016513668A (en) 2013-03-13 2016-05-16 タフツ・ユニバーシティ Uridine nucleoside derivatives, compositions and methods of use
CN103342672B (en) * 2013-07-02 2015-12-23 扬州大学 New synthetic methods substituted pyrrolidin-2-one
JP6453632B2 (en) * 2013-12-05 2019-01-16 株式会社日本触媒 Cyclic amide acrylate-containing compositions and methods of manufacturing
JP6465634B2 (en) * 2013-12-05 2019-02-06 株式会社日本触媒 Cyclic amide group-containing polymer
MX2016007808A (en) 2013-12-20 2016-09-07 Agenebio Inc Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment.
CN109999033A (en) 2014-01-21 2019-07-12 詹森药业有限公司 Positive allosteric modulator or the combination of normotopia agonist including metabotropic glutamate energy receptor subtype 2 and application thereof
CN104098497B (en) * 2014-06-17 2016-04-13 王庚禹 A new amide compound
WO2016075082A1 (en) 2014-11-10 2016-05-19 Sandoz Ag Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
US20180021307A1 (en) 2015-02-20 2018-01-25 Ucb Biopharma Sprl Combination Treatment
MX2017015133A (en) 2015-05-25 2018-08-01 Suzhou Pengxu Pharmatech Co Ltd Processes to produce brivaracetam.
CN106365986B (en) * 2015-07-21 2019-01-08 苏州鹏旭医药科技有限公司 Compound and preparation method thereof and the purposes in synthesis Bu Waxitan
EP3371150A1 (en) 2015-11-03 2018-09-12 UCB Biopharma SPRL Process for preparing brivaracetam
WO2017076737A1 (en) 2015-11-03 2017-05-11 Ucb Biopharma Sprl Continuous process for preparing brivaracetam
CN105646319B (en) * 2015-12-30 2018-05-18 佛山市隆信医药科技有限公司 Seed preparation Bois racetam
RU2629117C1 (en) * 2016-06-14 2017-08-24 Сизов Владимир Владимирович Method of producing 4-substituted 2-[2-oxo-1-pyrrolidinyl] acetamide
WO2018141276A1 (en) * 2017-02-05 2018-08-09 苏州鹏旭医药科技有限公司 Crystal form a of brivaracetam intermediate and preparation method thereof, and crystal form c of brivaracetam and preparation method thereof
CN106866483A (en) * 2017-02-05 2017-06-20 苏州鹏旭医药科技有限公司 Brivaraceta crystal form C and preparation method thereof
CN107721896A (en) * 2017-10-19 2018-02-23 丽珠集团新北江制药股份有限公司 Preparation method for brivaracetam intermediate
CN107793342A (en) * 2017-10-19 2018-03-13 丽珠集团新北江制药股份有限公司 Preparation method of brivaracetam
WO2019108974A1 (en) 2017-11-30 2019-06-06 Centurion Biopharma Corporation Albumin-binding prodrugs of auristatin e derivatives
WO2019108975A1 (en) 2017-11-30 2019-06-06 Centurion Biopharma Corporation Maytansinoid-based drug delivery systems
CN108147988A (en) * 2018-02-13 2018-06-12 扬州奥锐特药业有限公司 Method for preparing lactam compounds with high chiral purity

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD92031A (en) *
DE92031C (en)
US2836599A (en) * 1957-03-07 1958-05-27 Aerojet General Co Nu-(carboxyalkyl) dinitro lactams
GB1039113A (en) 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
HU177239B (en) 1974-10-15 1981-08-28 Monsanto Co Process for preparing n-acetamido-l-alanine derivatives by means of the asymmetric catalytic hydrogenation of alpha-acetamido-acrylic acid derivatives
US4008281A (en) 1973-12-03 1977-02-15 Monsanto Company Asymmetric catalysis
GB8412358D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
JPS6245238B2 (en) 1984-09-28 1987-09-25 Kazuo Achinami
CH666891A5 (en) * 1985-11-26 1988-08-31 Lonza Ag 4-alkoxy-2-oxo-pyrrolidin-1-yl-acetic acid c (1) -C (4) alkyl esters, their preparation and use.
DE3719873A1 (en) * 1987-06-13 1988-12-29 Basf Ag A process for producing itaconic acid diesters and itaconic acid
JPH0757758B2 (en) 1988-10-24 1995-06-21 高砂香料工業株式会社 Ruthenium - phosphine complex
GB8827389D0 (en) 1988-11-23 1988-12-29 Ucb Sa Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide
CA2067614C (en) * 1991-05-02 2002-07-30 Eiichi Otomo Agent for improving dementia
US5171892A (en) 1991-07-02 1992-12-15 E. I. Du Pont De Nemours And Company Chiral phospholanes via chiral 1,4-diol cyclic sulfates
GB9319732D0 (en) * 1993-09-24 1993-11-10 Ucb Sa Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety
JPH1180027A (en) * 1997-09-12 1999-03-23 Dai Ichi Seiyaku Co Ltd Intellect activator
TW544311B (en) * 1998-08-06 2003-08-01 Daiichi Seiyaku Co Therapeutic or preventive agent for intractable epilepsies
CZ20001055A3 (en) * 1998-10-02 2000-08-16 Dupont Pharmaceuticals Company Novel lactam inhibitors of metalloprotease
AT361751T (en) 1999-12-01 2007-06-15 Ucb Sa A pyrrolidinacetatderivat for treatment of chronic or neuropathic pain
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6686477B2 (en) 2000-09-29 2004-02-03 Eastman Chemical Company Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same

Also Published As

Publication number Publication date
HU230270B1 (en) 2015-11-30
BRPI0108664B1 (en) 2016-07-26
DE60119397T2 (en) 2007-04-19
RU2002124865A (en) 2004-01-10
BG109297A (en) 2006-06-30
JP2003528828A (en) 2003-09-30
PT1452524E (en) 2010-01-18
US8492416B2 (en) 2013-07-23
IS7923A (en) 2005-06-29
DE60119397D1 (en) 2006-06-08
PL213669B1 (en) 2013-04-30
NO20023995D0 (en) 2002-08-22
IS2176B (en) 2006-12-15
US20030040631A1 (en) 2003-02-27
RO121597B1 (en) 2007-12-28
NO20023997D0 (en) 2002-08-22
EP1577295A1 (en) 2005-09-21
HU229514B1 (en) 2014-01-28
EP1263727B1 (en) 2004-11-17
KR100720784B1 (en) 2007-05-23
US20050159475A1 (en) 2005-07-21
WO2001062726A3 (en) 2002-01-17
KR100681580B1 (en) 2007-02-09
US20050171187A1 (en) 2005-08-04
BR0108657A (en) 2003-04-29
CN1680314A (en) 2005-10-12
EP1604979A1 (en) 2005-12-14
ME00595B (en) 2011-12-20
TW200626545A (en) 2006-08-01
US20040087646A1 (en) 2004-05-06
NL300815I2 (en) 2016-07-27
GB0004297D0 (en) 2000-04-12
AU2005200717B2 (en) 2007-05-17
US6806287B2 (en) 2004-10-19
IS7921A (en) 2005-06-29
EP1477478B1 (en) 2010-11-17
AU778510B2 (en) 2004-12-09
CZ20022850A3 (en) 2003-02-12
RO121559B1 (en) 2007-11-30
JP2006022107A (en) 2006-01-26
NO324485B1 (en) 2007-10-29
DE60113514T2 (en) 2006-05-18
RU2006125756A (en) 2008-01-27
EP1452524B1 (en) 2009-10-14
IS6481A (en) 2002-07-23
IL166768A (en) 2010-04-15
IS2119B (en) 2006-06-15
EP1477478A3 (en) 2004-11-24
IS7920A (en) 2005-06-29
CU23201A3 (en) 2007-04-06
EP1452524A1 (en) 2004-09-01
BG65923B1 (en) 2010-05-31
IL150757D0 (en) 2003-02-12
WO2001064637A1 (en) 2001-09-07
EP1447399B1 (en) 2006-05-03
AT488500T (en) 2010-12-15
NO2016005I1 (en) 2016-03-08
DE60107216T2 (en) 2005-11-03
MY139420A (en) 2009-09-30
ES2334998T3 (en) 2010-03-18
US6784197B2 (en) 2004-08-31
PL359388A1 (en) 2004-08-23
SA1463B1 (en) 2006-10-29
EP1265862A2 (en) 2002-12-18
AU2005200718A1 (en) 2005-03-17
AT445597T (en) 2009-10-15
IL150842A (en) 2008-06-05
US20030120080A1 (en) 2003-06-26
HU0204526A2 (en) 2003-04-28
YU63102A (en) 2005-09-19
AU7389601A (en) 2001-09-12
IS7918A (en) 2005-06-29
DK1265862T3 (en) 2006-01-30
CU23293B7 (en) 2008-06-30
US6969770B2 (en) 2005-11-29
BG107016A (en) 2003-04-30
US20100222576A1 (en) 2010-09-02
SI1265862T1 (en) 2006-02-28
NO2016005I2 (en) 2016-03-08
AU2005200718B2 (en) 2007-05-24
NO20023995L (en) 2002-10-21
PL212197B1 (en) 2012-08-31
AU2005200717A1 (en) 2005-03-17
US20080097109A1 (en) 2008-04-24
HU0300196A2 (en) 2003-06-28
EP1477478A2 (en) 2004-11-17
LTC1265862I2 (en) 2017-06-12
CZ20022849A3 (en) 2003-02-12
MEP6109A (en) 2011-12-20
CZ304702B6 (en) 2014-09-03
RU2355680C2 (en) 2009-05-20
RU2005125569A (en) 2007-02-20
HU0500902D0 (en) 2005-12-28
MXPA02008206A (en) 2004-04-05
CZ304420B6 (en) 2014-04-30
DE60107216D1 (en) 2004-12-23
EP1447399B9 (en) 2006-10-18
CA2401048A1 (en) 2001-09-07
SA1275B1 (en) 2006-09-19
JP4938259B2 (en) 2012-05-23
US6713635B2 (en) 2004-03-30
CY1109718T1 (en) 2014-08-13
EG24375A (en) 2009-03-19
EP1577296A1 (en) 2005-09-21
RS50454B (en) 2010-03-02
BG65803B1 (en) 2009-12-31
US6911461B2 (en) 2005-06-28
CN1740150A (en) 2006-03-01
YU63202A (en) 2005-09-19
HU0300196A3 (en) 2005-10-28
BG65783B1 (en) 2009-11-30
US20050171188A1 (en) 2005-08-04
US20040116507A1 (en) 2004-06-17
AU2001252144B2 (en) 2005-04-28
JP2003523996A (en) 2003-08-12
IL170181A (en) 2010-11-30
NO20023997L (en) 2002-10-22
PL365159A1 (en) 2004-12-27
DE60113514D1 (en) 2005-10-27
US6858740B2 (en) 2005-02-22
NO324051B1 (en) 2007-08-06
US7217826B2 (en) 2007-05-15
CN1404470A (en) 2003-03-19
ZA200205837B (en) 2003-11-04
DK1447399T3 (en) 2006-08-28
HK1052695A1 (en) 2005-05-06
ES2248307T3 (en) 2006-03-16
CN1740151A (en) 2006-03-01
JP4769756B2 (en) 2011-09-07
CN1303066C (en) 2007-03-07
US7692028B2 (en) 2010-04-06
AT282592T (en) 2004-12-15
AT325093T (en) 2006-06-15
RS50455B (en) 2010-03-02
HK1052516A1 (en) 2006-02-10
NO20053644L (en) 2002-10-22
NZ520448A (en) 2004-03-26
PT1447399E (en) 2006-09-29
CO5280059A1 (en) 2003-05-30
DE60143493D1 (en) 2010-12-30
IS7919A (en) 2005-06-29
IS7922A (en) 2005-06-29
CN1179944C (en) 2004-12-15
IL166768D0 (en) 2006-01-15
CA2401048C (en) 2009-01-20
DE60140222D1 (en) 2009-11-26
AU5214401A (en) 2001-09-03
RU2292336C2 (en) 2007-01-27
JP4081275B2 (en) 2008-04-23
ES2355140T3 (en) 2011-03-23
NO20053645L (en) 2002-10-22
CA2401033C (en) 2008-07-29
US8034958B2 (en) 2011-10-11
US20040192757A1 (en) 2004-09-30
ES2231501T3 (en) 2005-05-16
JP2006022108A (en) 2006-01-26
RU2005125645A (en) 2007-02-20
US7358276B2 (en) 2008-04-15
US20120035239A1 (en) 2012-02-09
KR20050090090A (en) 2005-09-12
CN1404469A (en) 2003-03-19
LU92993I2 (en) 2016-05-11
MXPA02008056A (en) 2004-08-12
JP4121744B2 (en) 2008-07-23
IS2754B (en) 2011-09-15
RU2291860C3 (en) 2017-11-16
IS6472A (en) 2002-07-16
TW200626544A (en) 2006-08-01
RU2291860C2 (en) 2007-01-20
EP1447399A1 (en) 2004-08-18
CA2401033A1 (en) 2001-08-30
DK1452524T3 (en) 2010-03-01
US20040092576A1 (en) 2004-05-13
EP1263727A1 (en) 2002-12-11
CN1208319C (en) 2005-06-29
PL210121B1 (en) 2011-12-30
ES2264060T3 (en) 2006-12-16
WO2001062726A2 (en) 2001-08-30
MY140593A (en) 2009-12-31
CO5271667A1 (en) 2003-04-30
KR20050091112A (en) 2005-09-14
JP2007182459A (en) 2007-07-19
AU2001252144C1 (en) 2008-03-20
BG107004A (en) 2003-04-30
AT304999T (en) 2005-10-15
BR0108664A (en) 2003-04-29
MY138966A (en) 2008-08-28
ZA200205671B (en) 2003-11-10
EP1265862B1 (en) 2005-09-21
HU0204526A3 (en) 2005-03-29

Similar Documents

Publication Publication Date Title
TWI312369B (en) A-isomaltosylglucosaccharide synthase,process for producing the same and use thereof
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
RU2291860C3 (en) Derivatives 2-oxo-1-pyrrolidine, method for their production and application
MXPA03004114A (en) Cyanopyrrolidine derivatives.
PL366292A1 (en) Polyammonium-polysiloxane compounds, methods for the production and use thereof
HRP20010677A2 (en) 16-halogen-epothilone derivatives, method for prod
MXPA03001775A (en) Nucleoside derivatives.
ZA200402808B (en) Components and method for improved impression making.
HK1048311A1 (en) Compounds, their use and preparation
HK1040709A1 (en) Antiparasitic artemisinin derivatives, process for preparing composition and uses
EP1463412A4 (en) Composition comprising wenguanguo extracts, methods for preparing same and uses therof
ZA200202654B (en) Benzodiazepine derivatives.
PL347506A1 (en) 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
AU9289801A (en) Substituted azepinoÝ4,5b)indole derivatives
HK1044338A1 (en) 5-Pyridyl-1, 3-azole compounds, process for producing the same and use thereof
AU8009901A (en) 4-acylaminopyrazole derivatives
HRP20020960A2 (en) 2-aminocarbonyl-9h-purine derivatives
PL361625A1 (en) Article authentication
GB9903830D0 (en) Process-systems integration method
HRP20030055A2 (en) 4-phenyl-pyridine derivatives
HK1062911A1 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
HK1051038A1 (en) Benzodiazepine derivatives.
ZA200209266B (en) Novel phenyl-propargylether derivatives.
ZA200109841B (en) 5-cyano-2-aminopyrimidine derivatives.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.

Legal Events

Date Code Title Description
FF Patents granted
FF Patents granted